Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TRIAPRIN

ACETAMINOPHEN; BUTALBITAL

Standard Dose
325MG;50MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview TRIAPRIN is listed in Drugs@FDA under application 089268 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; BUTALBITAL Form and strength CAPSULE;ORAL - 325MG;50MG Sponsor DUNHALL Submission history Latest submission status date: 1987-07-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRIAPRIN is listed in Drugs@FDA under application 089268 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; BUTALBITAL Form and strength CAPSULE;ORAL - 325MG;50MG Sponsor DUNHALL Submission history Latest submission status date: 1987-07-02 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
TRIAPRIN (ACETAMINOPHEN; BUTALBITAL) | Drug Monograph | MedicHelpline